|
⚲
|
| Keyboard |
| Boyle Scott N
✚
|
|
|---|---|
| CIK # | 0001913897 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001913897] | |
| 4 | [0001913897] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| C4 Therapeutics Inc | |
| Boyle Scott N |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Tax withheld | 7,269 | $1.89 | 13,738 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Option exercise | 20,950 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Tax withheld | 1,735 | $1.89 | 3,279 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Grant | 200,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Option exercise | 5,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-18 | Sell | 669 | $3.15 | 2,107 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 84,700 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Tax withheld | 2,368 | $3.18 | 7,530 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Sell | 490 | $3.15 | 1,544 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Grant | 56,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-13 | Tax withheld | 1,735 | $3.20 | 5,552 |
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-11-07 | Option exercise | 3,750 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Option exercise | 3,750 | ||
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Tax withheld | 1,102 | $6.04 | 6,656 |
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-09-16 | Option exercise | 2,250 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Option exercise | 2,250 | ||
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Tax withheld | 661 | $6.36 | 4,204 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Grant | 115,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Disposed to issuer | 115,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-02-14 | Grant | 27,300 | $0.00 | |
| showing 20 of 33 most recent transactions | |||||